Ruppin D C, Murphy G M, Dowling R H
Gut. 1986 May;27(5):559-66. doi: 10.1136/gut.27.5.559.
Although bile acid and bile lipid metabolism have been studied in established cholelithiasis, little is known about them in patients destined to develop gall stones, but in whom the stones have not yet appeared (prestone gall stone disease). After confirmed complete gall stone dissolution and withdrawal of treatment, gall stones recur frequently. Before the stones reappear, these patients have 'poststone gall stone disease'. In 13 such patients we confirmed complete gall stone dissolution with two normal cholecystograms and in 11 of the 13 by normal ultrasonography, measured bile acid and bile lipid composition in fasting duodenal bile, bile acid synthesis from marker corrected three day faecal bile acid excretion, bile acid pool size using an abbreviated isotope dilution technique, 'steady-state' bile lipid secretion using a duodenal amino acid perfusion system and then calculated the enterohepatic cycling frequency of the bile acid pool and the relationship between pool size and body weight. The results confirm that after withdrawal of treatment the biliary cholesterol saturation index reverts to levels (1.6 +/- SEM 0.4) comparable with those before dissolution therapy first began (1.6 +/- 0.2; NS). The mean bile acid pool size in the 13 patients of 4.4 +/- 0.5 mmol was comparable with that in untreated gall stone patients. Pool size was significantly smaller in the nine non-obese patients (3.5 +/- 0.3), than in the four obese (6.0 +/- 0.8; p less than 0.05). It also correlated significantly with body weight (r = 0.72) and with %IBW (r = 0.79). The coefficients of variation for biliary bile acid, phospholipid and cholesterol secretion were high, but the mean hourly secretion rates were of the same order as those seen in untreated gall stone patients studied with the amino acid duodenal perfusion stimulus. These results provide a baseline for assessing the response to postdissolution treatment and may indicate metabolic events leading to gall stone formation.
尽管胆汁酸和胆汁脂质代谢已在已确诊的胆石症中得到研究,但对于注定会患胆结石但结石尚未出现(结石前期胆石病)的患者,人们对其了解甚少。在确认胆结石完全溶解且停止治疗后,胆结石经常复发。在结石再次出现之前,这些患者患有“结石后胆石病”。在13例此类患者中,我们通过两次正常的胆囊造影证实胆结石完全溶解,13例中有11例通过超声检查正常,测量了空腹十二指肠胆汁中的胆汁酸和胆汁脂质成分,根据标记物校正的三天粪便胆汁酸排泄量计算胆汁酸合成,使用简化的同位素稀释技术测量胆汁酸池大小,使用十二指肠氨基酸灌注系统测量“稳态”胆汁脂质分泌,然后计算胆汁酸池的肠肝循环频率以及池大小与体重之间的关系。结果证实,停止治疗后,胆汁胆固醇饱和指数恢复到与首次开始溶解治疗前相当的水平(1.6±标准误0.4)(首次开始溶解治疗前为1.6±0.2;无显著性差异)。13例患者的平均胆汁酸池大小为4.4±0.5 mmol,与未治疗胆结石患者相当。9例非肥胖患者(3.5±0.3)胆汁酸池大小明显小于4例肥胖患者(6.0±0.8;P<0.05)。它还与体重(r = 0.72)和%理想体重(r = 0.79)显著相关。胆汁中胆汁酸、磷脂和胆固醇分泌的变异系数较高,但平均每小时分泌率与用氨基酸十二指肠灌注刺激研究的未治疗胆结石患者所见的分泌率处于同一水平。这些结果为评估溶解后治疗的反应提供了基线,并可能表明导致胆结石形成的代谢事件。